Form EFFECT Astria Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 27, 2026 |
| Accession Number: | 0001140361-26-002204 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karus Hits 14.6 Metres of 4.8g/t Gold in First Two of 11 Holes Testing High-Grade Structural Controls at FG Gold Project
- Ewing Morris Announces Premium All-Cash Offer to Acquire Shares of Decibel Cannabis Company Inc.
- Thunder Gold Intersects Continuous Gold Mineralization Averaging 1.178 g/t Au Over 102.0 Metres at Tower Mountain, Ontario
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share